Sunday, October 23, 2016

Most Cited Article: Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A

  11:26 PM   No comments   Edit
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A Author(s): I. Gentile, F. Borgia, N. Coppola, A.R. Buonomo, G. Castaldo and G. Borgia   Pages 1391-1404 (14) Abstract: Hepatitis C virus (HCV) infection affects about 160 million people worldwide. It is treated with pegylatedinterferon (peg-IFN) and ribavirin, and in the case of patients affected...

Monday, October 17, 2016

Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels Volume 23, Issue 22

  11:53 PM   No comments   Edit
Article Details Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels [ Vol. 23 , Issue. 22 ] Author(s): Roberta Gualdani, Maria Maddalena Cavalluzzi and Giovanni LentiniPages 2289-2332 (44) Abstract: Voltage-gated sodium channels (VGSC) are responsible for the selective influx of sodium ions in excitable cells. A number of physiological phenomena such as muscle...

Sunday, October 9, 2016

Tuesday, October 4, 2016

Current Medicinal Chemistry , 23 Issue 21

  10:56 PM   No comments   Edit
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal...

Current Medicinal Chemistry, 23 Issue 15

  10:55 PM   No comments   Edit
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal...
Subscribe to: Posts (Atom)